Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 2 Outcome data for patient and renal survival

From: Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study

Absolute time since PLEX Surviving, n (%) RRT in survivors, n (%)
0 months (n = 94) 94 (100 %) 55 (58.5 %)
3 months (n = 94) 81 (86.2 %) 19 (23.5 %)
1 year (n = 94) 68 (72.3 %) 14 (20.6 %)
3 years (n = 79) 49 (62 %) 9 (18.4 %)
5 years (n = 61) 26 (42.6 %) 5 (19.2 %)
End of follow-up (n = 94) 56 (59.6 %) 9 (16.1 %)
  1. PLEX plasma exchange, RRT renal replacement therapy